Detalhe da pesquisa
1.
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension.
Eur J Nucl Med Mol Imaging
; 48(4): 1081-1092, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33009594
2.
(+)-[18F]Flubatine as a novel α4ß2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with ß-amyloid PET-confirmed Alzheimer's disease and healthy controls.
Eur J Nucl Med Mol Imaging
; 48(3): 731-746, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935187
3.
Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls.
Stress
; 22(1): 93-102, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30369292
4.
Cognitive correlates of α4ß2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
Brain
; 141(6): 1840-1854, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29672680
5.
Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults.
Eur J Nucl Med Mol Imaging
; 45(9): 1618-1625, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29627935
6.
Test-retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging.
Eur J Nucl Med Mol Imaging
; 44(6): 1025-1032, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28197685
7.
Central noradrenaline transporter availability in highly obese, non-depressed individuals.
Eur J Nucl Med Mol Imaging
; 44(6): 1056-1064, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28066877
8.
Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non-obese individuals.
Eur J Neurosci
; 44(7): 2460-2466, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27519298
9.
Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease.
Eur J Nucl Med Mol Imaging
; 43(9): 1700-9, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27026271
10.
Evaluation of software tools for automated identification of neuroanatomical structures in quantitative ß-amyloid PET imaging to diagnose Alzheimer's disease.
Eur J Nucl Med Mol Imaging
; 43(6): 1077-87, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26739328
11.
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.
Eur J Nucl Med Mol Imaging
; 43(6): 1096-104, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26577939
12.
First-in-human PET quantification study of cerebral α4ß2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Neuroimage
; 118: 199-208, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26037057
13.
Altered serotonin transporter availability in patients with multiple sclerosis.
Eur J Nucl Med Mol Imaging
; 41(5): 827-35, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24562640
14.
Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study.
Biol Psychiatry
; 93(12): 1081-1088, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997451
15.
Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.
Eur J Nucl Med Mol Imaging
; 39(6): 1001-11, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22349718
16.
HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls.
Brain Sci
; 12(11)2022 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358358
17.
Availability of Central α4ß2* Nicotinic Acetylcholine Receptors in Human Obesity.
Brain Sci
; 12(12)2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36552108
18.
Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity.
Brain Sci
; 12(11)2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358364
19.
Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment.
Neuroimage
; 56(1): 93-101, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21276863
20.
The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
Int J Neuropsychopharmacol
; 14(5): 606-17, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21232166